Cargando…

The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies

Tumor cells constantly interact with their microenvironment, which comprises a variety of immune cells together with endothelial cells and fibroblasts. The composition of the tumor microenvironment (TME) has been shown to influence response to immune checkpoint blockade (ICB). ICB takes advantage of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Petitprez, Florent, Meylan, Maxime, de Reyniès, Aurélien, Sautès-Fridman, Catherine, Fridman, Wolf H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221158/ https://www.ncbi.nlm.nih.gov/pubmed/32457745 http://dx.doi.org/10.3389/fimmu.2020.00784

Ejemplares similares

Quantitative Analyses of the Tumor Microenvironment Composition and Orientation in the Era of Precision Medicine
por: Petitprez, Florent, et al.
Publicado: (2018)

The murine Microenvironment Cell Population counter method to estimate abundance of tissue-infiltrating immune and stromal cell populations in murine samples using gene expression
por: Petitprez, Florent, et al.
Publicado: (2020)

Review of Prognostic Expression Markers for Clear Cell Renal Cell Carcinoma
por: Petitprez, Florent, et al.
Publicado: (2021)

B cells and cancer: To B or not to B?
por: Fridman, Wolf Herman, et al.
Publicado: (2020)

Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
por: Becht, Etienne, et al.
Publicado: (2016)

Erratum to: Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
por: Becht, Etienne, et al.
Publicado: (2016)

The Ultimate Goal of Curative Anti-Cancer Therapies: Inducing an Adaptive Anti-Tumor Immune Response
por: Fridman, Wolf H., et al.
Publicado: (2011)

Tumor microenvironment in NSCLC suppresses NK cells function
por: Cremer, Isabelle, et al.
Publicado: (2012)

Lung Tumor Microenvironment Induces Specific Gene Expression Signature in Intratumoral NK Cells
por: Gillard-Bocquet, Mélanie, et al.
Publicado: (2013)

Tumor Immunology, toward a Success Story?
por: Sautès-Fridman, Catherine
Publicado: (2015)

Integrating tumor microenvironment with cancer molecular classifications
por: Becht, Etienne, et al.
Publicado: (2015)

Influence of Tumor Location on the Composition of Immune Infiltrate and Its Impact on Patient Survival. Lessons from DCBCL and Animal Models
por: Galand, Claire, et al.
Publicado: (2012)

Immune-Desert Tumor Microenvironment in Thoracic SMARCA4-Deficient Undifferentiated Tumors with Limited Efficacy of Immune Checkpoint Inhibitors
por: Gantzer, Justine, et al.
Publicado: (2022)

The nexus of dynamic T cell states and immune checkpoint blockade therapy in the periphery and tumor microenvironment
por: Luo, Hong, et al.
Publicado: (2023)

Lymphoma B-cell responsiveness to CpG-DNA depends on the tumor microenvironment
por: Ben Abdelwahed, Rym, et al.
Publicado: (2013)

Therapeutic Implications of Tumor Microenvironment in Lung Cancer: Focus on Immune Checkpoint Blockade
por: Genova, Carlo, et al.
Publicado: (2022)

Frontiers in Tumor Immunity: Grand Challenge “Cancer and Immunity: A Family Drama”
por: Fridman, Wolf-Hervé
Publicado: (2011)

Revisiting immune escape in colorectal cancer in the era of immunotherapy
por: Ijsselsteijn, Marieke Erica, et al.
Publicado: (2019)

Editorial: Tertiary Lymphoid Structures: From Basic Biology to Translational Impact in Cancer
por: Sautès-Fridman, Catherine, et al.
Publicado: (2022)

Growth/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune Checkpoint
por: Wischhusen, Jörg, et al.
Publicado: (2020)

The European Academy of Tumor Immunology: Bridging fields, continents and generations
por: Kroemer, Guido, et al.
Publicado: (2012)

Sensitizing the Tumor Microenvironment to Immune Checkpoint Therapy
por: Zemek, Rachael M., et al.
Publicado: (2020)

Antimetabolite pemetrexed primes a favorable tumor microenvironment for immune checkpoint blockade therapy
por: Lu, Chia-Sing, et al.
Publicado: (2020)

The immune microenvironment as a guide for cancer therapies
por: Fridman, Wolf H.
Publicado: (2012)

Tertiary Lymphoid Structures in Cancers: Prognostic Value, Regulation, and Manipulation for Therapeutic Intervention
por: Sautès-Fridman, Catherine, et al.
Publicado: (2016)

Manipulation of the crosstalk between tumor angiogenesis and immunosuppression in the tumor microenvironment: Insight into the combination therapy of anti-angiogenesis and immune checkpoint blockade
por: Zheng, Weiwei, et al.
Publicado: (2022)

Tertiary lymphoid structures in human lung cancers, a new driver of antitumor immune responses
por: Goc, Jérémy, et al.
Publicado: (2014)

Prognostic and theranostic impact of molecular subtypes and immune classifications in renal cell cancer (RCC) and colorectal cancer (CRC)
por: Becht, Etienne, et al.
Publicado: (2015)

The clinical role of the TME in solid cancer
por: Giraldo, Nicolas A., et al.
Publicado: (2018)

Editorial: Factors determining long term anti-tumor responses to immune checkpoint blockade therapy
por: Zappasodi, Roberta, et al.
Publicado: (2022)

Treatment Progress of Immune Checkpoint Blockade Therapy for Glioblastoma
por: Zhang, Na, et al.
Publicado: (2020)

Lighting a Fire: Gasdermin-Mediated Pyroptosis Remodels the Glioma Microenvironment and Promotes Immune Checkpoint Blockade Response
por: Cai, Yonghua, et al.
Publicado: (2022)

Editorial: Combinatorial Approaches to Enhance Anti-tumor Immunity: Focus on Immune Checkpoint Blockade Therapy
por: Andersson, Patrik, et al.
Publicado: (2019)

Conserved angio-immune subtypes of the tumor microenvironment predict response to immune checkpoint blockade therapy
por: Subramanian, Madhav, et al.
Publicado: (2023)

The Tumor Microenvironment Factors That Promote Resistance to Immune Checkpoint Blockade Therapy
por: Russell, Bonnie L., et al.
Publicado: (2021)

Hsp90β inhibition upregulates interferon response and enhances immune checkpoint blockade therapy in murine tumors
por: Rahmy, Sharif, et al.
Publicado: (2022)

Role of Tissue-Resident Memory in Intra-Tumor Heterogeneity and Response to Immune Checkpoint Blockade
por: Dhodapkar, Kavita M.
Publicado: (2018)

Advancing immune checkpoint blockade in colorectal cancer therapy with nanotechnology
por: Liu, Zefan, et al.
Publicado: (2022)

Factors Determining Long-Term Antitumor Responses to Immune Checkpoint Blockade Therapy in Melanoma
por: Loo, Kimberly, et al.
Publicado: (2022)

Natural killer cells in the human lung tumor microenvironment display immune inhibitory functions
por: Russick, Jules, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jrm889qslb03cpnt3g08f5kqeg